Clinical trials
Shock, Cardiogenic trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
79 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2012 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 4 |
| 2020 | 3 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 10 |
| 2024 | 8 |
| 2025 | 9 |
| 2026 | 14 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Recruiting | 22 |
| Not yet recruiting | 13 |
| Unknown status | 11 |
| Terminated | 4 |
| Withdrawn | 3 |
| Active, not recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Assistance Publique - Hôpitaux de Paris | 3 |
| Chonnam National University Hospital | 3 |
| Erasmus Medical Center | 3 |
| Abiomed Inc. | 2 |
| Beijing Anzhen Hospital | 2 |
| Central Hospital, Nancy, France | 2 |
| Leipzig Heart Science gGmbH | 2 |
| Min-Seok Kim | 2 |
| Renmin Hospital of Wuhan University | 2 |
| Rigshospitalet, Denmark | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shock, Cardiogenic | 79 |
| Heart Failure | 12 |
| Myocardial Infarction | 9 |
| Cardiovascular Diseases | 4 |
| Heart Arrest | 4 |
| Respiratory Distress Syndrome | 4 |
| ST Elevation Myocardial Infarction | 4 |
| Coronary Disease | 3 |
| Shock | 3 |
| Acute Coronary Syndrome | 2 |
Trials
Showing 1 to 25 of 79. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.